Patent · US Active

C-terminal lysine conjugated immunoglobulins

US12214050B2 · kind B2 · utility

0Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 2021
Grant dateFeb 4, 2025
Priority date—
Expiry dateOct 1, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are conjugated immunoglobulins and methods for generating conjugated immunoglobulins using a microbial transglutaminase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.